Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about JNJ
Recent news which mentions JNJ
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients
September 20, 2024
Tickers
JNJ
NEWS
Tags
Briefs
Stories That Matter
Benzinga
From
Benzinga
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
September 20, 2024
Tickers
JNJ
NEWS
ZVRA
Tags
Benzinga
Stories That Matter
Biotech
From
Benzinga
The Latest Analyst Ratings For Johnson & Johnson
September 19, 2024
Tickers
JNJ
Tags
Market News
JNJ
Benzinga
From
Benzinga
2 Vanguard Index Funds Could Turn $400 Per Month Into $16,800 in Annual Dividend Income by Retirement
September 19, 2024
Tickers
AAPL
AMZN
AVGO
GOOG
Tags
AVGO
MSFT
JNJ
From
Motley Fool
Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug
September 18, 2024
Tickers
AZN
BGNE
JNJ
NEWS
Tags
News
Large Cap
JNJ
From
Benzinga
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
Tickers
BNTX
JNJ
MRNA
NVAX
Tags
NVAX
Market News
BNTX
From
Motley Fool
Unpacking the Latest Options Trading Trends in Johnson & Johnson
September 12, 2024
Tickers
JNJ
Tags
Market News
Markets
Options
From
Benzinga
Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
September 12, 2024
Tickers
JNJ
NEWS
Tags
Market News
Markets
JNJ
From
Benzinga
How To Earn $500 A Month From Johnson & Johnson Stock
September 12, 2024
Tickers
JNJ
NEWS
Tags
$500 Dividend
JNJ
Earnings
From
Benzinga
Metals in Tampons: FDA Initiates New Safety Measures and Testing
September 11, 2024
Tickers
EPC
JNJ
KMB
NEWS
Tags
Benzinga
Stories That Matter
Briefs
From
Benzinga
Sony Music-Universal Music JV Hits Johnson & Johnson With Copyright Lawsuit Over Unlicensed Music Use Covering 80 Videos
September 11, 2024
Tickers
JNJ
NEWS
Tags
Briefs
Biotech
Benzinga
From
Benzinga
Johnson & Johnson's Mid-Stage Lung Cancer Trial Reveals Fewer Infusion-Related Reactions
September 11, 2024
Tickers
JNJ
NEWS
Tags
General
Stories That Matter
Benzinga
From
Benzinga
Is Hims & Hers Health the Next Teladoc?
September 11, 2024
Tickers
HIMS
JNJ
LLY
MRNA
Tags
Market News
MRNA
TDOC
From
Motley Fool
2 Stocks That Are Passive Income Machines to Buy and Hold Forever
September 11, 2024
Tickers
ABT
JNJ
Tags
Market News
Recent Press Releases
ABT
From
Motley Fool
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
September 10, 2024
Tickers
JNJ
NEWS
PTGX
TAK
Tags
Price Target
Briefs
Expert Ideas
From
Benzinga
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
September 10, 2024
Tickers
JNJ
KVUE
Tags
Market News
Pro Project
Signals
From
Benzinga
Dell, CoStar, PayPal And A Major Health Care Stock On CNBC's 'Final Trades'
September 06, 2024
Tickers
AAPL
CSGP
DELL
JNJ
Tags
Joshua Brown
Benzinga
Long Ideas
From
Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
September 06, 2024
Tickers
CVS
JNJ
NEWS
PDCO
Tags
Dividends
health care
dividend yield
From
Benzinga
Johnson & Johnson Raises Talc Settlement Offer to $9B, Moves Closer to Settlement Victory
September 05, 2024
Tickers
JNJ
NEWS
Tags
Biotech
Stories That Matter
Benzinga
From
Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
Tickers
ABBV
ATAI
CMPS
COMP
Tags
Psychedelics
Benzinga
ATAI Life Sciences
From
Benzinga
2 Dividend Stocks With Payouts That May Not Be as Safe as They Seem
September 05, 2024
Tickers
INTC
JNJ
MO
WBA
Tags
Market News
Recent Press Releases
JNJ
From
Motley Fool
Court Orders Johnson & Johnson To Compensate Auris Health Shareholders $1B
September 04, 2024
Tickers
JNJ
NEWS
Tags
Market News
AI Generated
Top Stories
From
Benzinga
3 Dividend Stocks to Double Up on Right Now
September 04, 2024
Tickers
JNJ
NKE
VZ
Tags
NKE
VZ
Market News
From
Motley Fool
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
Tickers
AMGN
AZN
BMY
JNJ
Tags
BMY
MRK
AZN
From
Benzinga
Critical Insights From Johnson & Johnson Analyst Ratings: What You Need To Know
September 03, 2024
Tickers
JNJ
Tags
JNJ
Benzinga
Market News
From
Benzinga
Is Johnson & Johnson the Best Dividend Stock for You?
September 01, 2024
Tickers
JNJ
Tags
Recent Press Releases
Market News
JNJ
From
Motley Fool
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.
September 01, 2024
Tickers
AMZN
CELH
ITW
JNJ
Tags
PEP
Market News
KO
From
Motley Fool
Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps
August 30, 2024
Tickers
ACI
JNJ
KVUE
NEWS
Tags
Market News
News
Large Cap
From
Benzinga
Johnson & Johnson's Golden Cross: A Bullish Prescription For Investors?
August 29, 2024
Tickers
JNJ
Tags
Market News
Signals
Top Stories
From
Benzinga
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
August 29, 2024
Tickers
ARGX
JNJ
NEWS
UCBJF
Tags
UCBJF
Market News
JNJ
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.